Global Recombinant DNA Technology Market to Reach $93.7 Billion by 2030
The global market for Recombinant DNA Technology estimated at US$64.7 Billion in the year 2022, is projected to reach a revised size of US$93.7 Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2022-2030. Medical, one of the segments analyzed in the report, is projected to record 5.2% CAGR and reach US$70.4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Non-Medical segment is readjusted to a revised 3.4% CAGR for the next 8-year period.
The U.S. Market is Estimated at $18.9 Billion, While China is Forecast to Grow at 4.4% CAGR
The Recombinant DNA Technology market in the U.S. is estimated at US$18.9 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$16.5 Billion by the year 2030 trailing a CAGR of 4.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.2% and 3.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.Select Competitors (Total 32 Featured) -
- Amgen Inc
- Bamboo Therapeutics, Inc.
- Biocon
- Biogen
- Chiron Corporation
- Cibus
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd
- Genentech, Inc
- GenScript
- GlaxoSmithKline plc.
- Horizon Discovery Group plc
- Merck KGaA
- Monsanto Company
- New England Biolabs
- Novartis AG
- Novo Nordisk A/S
- Nucelis
- Pfizer Inc.
- Profacgen
- Sanofi
- Syngene
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIV. COMPETITION
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Impact of Covid-19 and a Looming Global Recession
- Recombinant DNA Technology - Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recombinant DNA Technology Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Recombinant DNA Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 3: World Historic Review for Recombinant DNA Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 4: World 16-Year Perspective for Recombinant DNA Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Medical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 6: World Historic Review for Medical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 7: World 16-Year Perspective for Medical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Non-Medical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 9: World Historic Review for Non-Medical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 10: World 16-Year Perspective for Non-Medical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Expression System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 12: World Historic Review for Expression System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 13: World 16-Year Perspective for Expression System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Cloning Vector by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 15: World Historic Review for Cloning Vector by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 16: World 16-Year Perspective for Cloning Vector by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Health & Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 18: World Historic Review for Health & Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 19: World 16-Year Perspective for Health & Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Food & Agriculture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 21: World Historic Review for Food & Agriculture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 22: World 16-Year Perspective for Food & Agriculture by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for Environmental by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 24: World Historic Review for Environmental by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 25: World 16-Year Perspective for Environmental by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 27: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 28: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
TABLE 2: World Recent Past, Current & Future Analysis for Recombinant DNA Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 3: World Historic Review for Recombinant DNA Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 4: World 16-Year Perspective for Recombinant DNA Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Medical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 6: World Historic Review for Medical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 7: World 16-Year Perspective for Medical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Non-Medical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 9: World Historic Review for Non-Medical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 10: World 16-Year Perspective for Non-Medical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Expression System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 12: World Historic Review for Expression System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 13: World 16-Year Perspective for Expression System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Cloning Vector by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 15: World Historic Review for Cloning Vector by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 16: World 16-Year Perspective for Cloning Vector by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Health & Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 18: World Historic Review for Health & Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 19: World 16-Year Perspective for Health & Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Food & Agriculture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 21: World Historic Review for Food & Agriculture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 22: World 16-Year Perspective for Food & Agriculture by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for Environmental by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 24: World Historic Review for Environmental by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 25: World 16-Year Perspective for Environmental by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 27: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 28: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
III. MARKET ANALYSIS
UNITED STATES
TABLE 30: USA Historic Review for Recombinant DNA Technology by Product Type - Medical and Non-Medical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 31: USA 16-Year Perspective for Recombinant DNA Technology by Product Type - Percentage Breakdown of Value Sales for Medical and Non-Medical for the Years 2014, 2023 & 2030
TABLE 32: USA Recent Past, Current & Future Analysis for Recombinant DNA Technology by Type - Expression System and Cloning Vector - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 33: USA Historic Review for Recombinant DNA Technology by Type - Expression System and Cloning Vector Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 34: USA 16-Year Perspective for Recombinant DNA Technology by Type - Percentage Breakdown of Value Sales for Expression System and Cloning Vector for the Years 2014, 2023 & 2030
TABLE 35: USA Recent Past, Current & Future Analysis for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 36: USA Historic Review for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 37: USA 16-Year Perspective for Recombinant DNA Technology by Application - Percentage Breakdown of Value Sales for Health & Disease, Food & Agriculture, Environmental and Other Applications for the Years 2014, 2023 & 2030
CANADA
TABLE 38: Canada Recent Past, Current & Future Analysis for Recombinant DNA Technology by Product Type - Medical and Non-Medical - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 39: Canada Historic Review for Recombinant DNA Technology by Product Type - Medical and Non-Medical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 40: Canada 16-Year Perspective for Recombinant DNA Technology by Product Type - Percentage Breakdown of Value Sales for Medical and Non-Medical for the Years 2014, 2023 & 2030
TABLE 41: Canada Recent Past, Current & Future Analysis for Recombinant DNA Technology by Type - Expression System and Cloning Vector - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 42: Canada Historic Review for Recombinant DNA Technology by Type - Expression System and Cloning Vector Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 43: Canada 16-Year Perspective for Recombinant DNA Technology by Type - Percentage Breakdown of Value Sales for Expression System and Cloning Vector for the Years 2014, 2023 & 2030
TABLE 44: Canada Recent Past, Current & Future Analysis for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 45: Canada Historic Review for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 46: Canada 16-Year Perspective for Recombinant DNA Technology by Application - Percentage Breakdown of Value Sales for Health & Disease, Food & Agriculture, Environmental and Other Applications for the Years 2014, 2023 & 2030
JAPAN
TABLE 48: Japan Historic Review for Recombinant DNA Technology by Product Type - Medical and Non-Medical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 49: Japan 16-Year Perspective for Recombinant DNA Technology by Product Type - Percentage Breakdown of Value Sales for Medical and Non-Medical for the Years 2014, 2023 & 2030
TABLE 50: Japan Recent Past, Current & Future Analysis for Recombinant DNA Technology by Type - Expression System and Cloning Vector - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 51: Japan Historic Review for Recombinant DNA Technology by Type - Expression System and Cloning Vector Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 52: Japan 16-Year Perspective for Recombinant DNA Technology by Type - Percentage Breakdown of Value Sales for Expression System and Cloning Vector for the Years 2014, 2023 & 2030
TABLE 53: Japan Recent Past, Current & Future Analysis for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 54: Japan Historic Review for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 55: Japan 16-Year Perspective for Recombinant DNA Technology by Application - Percentage Breakdown of Value Sales for Health & Disease, Food & Agriculture, Environmental and Other Applications for the Years 2014, 2023 & 2030
CHINA
TABLE 57: China Historic Review for Recombinant DNA Technology by Product Type - Medical and Non-Medical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 58: China 16-Year Perspective for Recombinant DNA Technology by Product Type - Percentage Breakdown of Value Sales for Medical and Non-Medical for the Years 2014, 2023 & 2030
TABLE 59: China Recent Past, Current & Future Analysis for Recombinant DNA Technology by Type - Expression System and Cloning Vector - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 60: China Historic Review for Recombinant DNA Technology by Type - Expression System and Cloning Vector Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 61: China 16-Year Perspective for Recombinant DNA Technology by Type - Percentage Breakdown of Value Sales for Expression System and Cloning Vector for the Years 2014, 2023 & 2030
TABLE 62: China Recent Past, Current & Future Analysis for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 63: China Historic Review for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 64: China 16-Year Perspective for Recombinant DNA Technology by Application - Percentage Breakdown of Value Sales for Health & Disease, Food & Agriculture, Environmental and Other Applications for the Years 2014, 2023 & 2030
EUROPE
TABLE 66: Europe Historic Review for Recombinant DNA Technology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 67: Europe 16-Year Perspective for Recombinant DNA Technology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
TABLE 68: Europe Recent Past, Current & Future Analysis for Recombinant DNA Technology by Product Type - Medical and Non-Medical - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 69: Europe Historic Review for Recombinant DNA Technology by Product Type - Medical and Non-Medical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 70: Europe 16-Year Perspective for Recombinant DNA Technology by Product Type - Percentage Breakdown of Value Sales for Medical and Non-Medical for the Years 2014, 2023 & 2030
TABLE 71: Europe Recent Past, Current & Future Analysis for Recombinant DNA Technology by Type - Expression System and Cloning Vector - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 72: Europe Historic Review for Recombinant DNA Technology by Type - Expression System and Cloning Vector Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 73: Europe 16-Year Perspective for Recombinant DNA Technology by Type - Percentage Breakdown of Value Sales for Expression System and Cloning Vector for the Years 2014, 2023 & 2030
TABLE 74: Europe Recent Past, Current & Future Analysis for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 75: Europe Historic Review for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 76: Europe 16-Year Perspective for Recombinant DNA Technology by Application - Percentage Breakdown of Value Sales for Health & Disease, Food & Agriculture, Environmental and Other Applications for the Years 2014, 2023 & 2030
FRANCE
TABLE 78: France Historic Review for Recombinant DNA Technology by Product Type - Medical and Non-Medical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 79: France 16-Year Perspective for Recombinant DNA Technology by Product Type - Percentage Breakdown of Value Sales for Medical and Non-Medical for the Years 2014, 2023 & 2030
TABLE 80: France Recent Past, Current & Future Analysis for Recombinant DNA Technology by Type - Expression System and Cloning Vector - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 81: France Historic Review for Recombinant DNA Technology by Type - Expression System and Cloning Vector Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 82: France 16-Year Perspective for Recombinant DNA Technology by Type - Percentage Breakdown of Value Sales for Expression System and Cloning Vector for the Years 2014, 2023 & 2030
TABLE 83: France Recent Past, Current & Future Analysis for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 84: France Historic Review for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 85: France 16-Year Perspective for Recombinant DNA Technology by Application - Percentage Breakdown of Value Sales for Health & Disease, Food & Agriculture, Environmental and Other Applications for the Years 2014, 2023 & 2030
GERMANY
TABLE 87: Germany Historic Review for Recombinant DNA Technology by Product Type - Medical and Non-Medical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 88: Germany 16-Year Perspective for Recombinant DNA Technology by Product Type - Percentage Breakdown of Value Sales for Medical and Non-Medical for the Years 2014, 2023 & 2030
TABLE 89: Germany Recent Past, Current & Future Analysis for Recombinant DNA Technology by Type - Expression System and Cloning Vector - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 90: Germany Historic Review for Recombinant DNA Technology by Type - Expression System and Cloning Vector Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 91: Germany 16-Year Perspective for Recombinant DNA Technology by Type - Percentage Breakdown of Value Sales for Expression System and Cloning Vector for the Years 2014, 2023 & 2030
TABLE 92: Germany Recent Past, Current & Future Analysis for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 93: Germany Historic Review for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 94: Germany 16-Year Perspective for Recombinant DNA Technology by Application - Percentage Breakdown of Value Sales for Health & Disease, Food & Agriculture, Environmental and Other Applications for the Years 2014, 2023 & 2030
ITALY
TABLE 95: Italy Recent Past, Current & Future Analysis for Recombinant DNA Technology by Product Type - Medical and Non-Medical - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 96: Italy Historic Review for Recombinant DNA Technology by Product Type - Medical and Non-Medical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 97: Italy 16-Year Perspective for Recombinant DNA Technology by Product Type - Percentage Breakdown of Value Sales for Medical and Non-Medical for the Years 2014, 2023 & 2030
TABLE 98: Italy Recent Past, Current & Future Analysis for Recombinant DNA Technology by Type - Expression System and Cloning Vector - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 99: Italy Historic Review for Recombinant DNA Technology by Type - Expression System and Cloning Vector Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 100: Italy 16-Year Perspective for Recombinant DNA Technology by Type - Percentage Breakdown of Value Sales for Expression System and Cloning Vector for the Years 2014, 2023 & 2030
TABLE 101: Italy Recent Past, Current & Future Analysis for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 102: Italy Historic Review for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 103: Italy 16-Year Perspective for Recombinant DNA Technology by Application - Percentage Breakdown of Value Sales for Health & Disease, Food & Agriculture, Environmental and Other Applications for the Years 2014, 2023 & 2030
UNITED KINGDOM
TABLE 105: UK Historic Review for Recombinant DNA Technology by Product Type - Medical and Non-Medical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 106: UK 16-Year Perspective for Recombinant DNA Technology by Product Type - Percentage Breakdown of Value Sales for Medical and Non-Medical for the Years 2014, 2023 & 2030
TABLE 107: UK Recent Past, Current & Future Analysis for Recombinant DNA Technology by Type - Expression System and Cloning Vector - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 108: UK Historic Review for Recombinant DNA Technology by Type - Expression System and Cloning Vector Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 109: UK 16-Year Perspective for Recombinant DNA Technology by Type - Percentage Breakdown of Value Sales for Expression System and Cloning Vector for the Years 2014, 2023 & 2030
TABLE 110: UK Recent Past, Current & Future Analysis for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 111: UK Historic Review for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 112: UK 16-Year Perspective for Recombinant DNA Technology by Application - Percentage Breakdown of Value Sales for Health & Disease, Food & Agriculture, Environmental and Other Applications for the Years 2014, 2023 & 2030
REST OF EUROPE
TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Recombinant DNA Technology by Product Type - Medical and Non-Medical - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 114: Rest of Europe Historic Review for Recombinant DNA Technology by Product Type - Medical and Non-Medical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 115: Rest of Europe 16-Year Perspective for Recombinant DNA Technology by Product Type - Percentage Breakdown of Value Sales for Medical and Non-Medical for the Years 2014, 2023 & 2030
TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Recombinant DNA Technology by Type - Expression System and Cloning Vector - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 117: Rest of Europe Historic Review for Recombinant DNA Technology by Type - Expression System and Cloning Vector Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 118: Rest of Europe 16-Year Perspective for Recombinant DNA Technology by Type - Percentage Breakdown of Value Sales for Expression System and Cloning Vector for the Years 2014, 2023 & 2030
TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 120: Rest of Europe Historic Review for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 121: Rest of Europe 16-Year Perspective for Recombinant DNA Technology by Application - Percentage Breakdown of Value Sales for Health & Disease, Food & Agriculture, Environmental and Other Applications for the Years 2014, 2023 & 2030
ASIA-PACIFIC
TABLE 123: Asia-Pacific Historic Review for Recombinant DNA Technology by Product Type - Medical and Non-Medical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 124: Asia-Pacific 16-Year Perspective for Recombinant DNA Technology by Product Type - Percentage Breakdown of Value Sales for Medical and Non-Medical for the Years 2014, 2023 & 2030
TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Recombinant DNA Technology by Type - Expression System and Cloning Vector - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 126: Asia-Pacific Historic Review for Recombinant DNA Technology by Type - Expression System and Cloning Vector Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 127: Asia-Pacific 16-Year Perspective for Recombinant DNA Technology by Type - Percentage Breakdown of Value Sales for Expression System and Cloning Vector for the Years 2014, 2023 & 2030
TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 129: Asia-Pacific Historic Review for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 130: Asia-Pacific 16-Year Perspective for Recombinant DNA Technology by Application - Percentage Breakdown of Value Sales for Health & Disease, Food & Agriculture, Environmental and Other Applications for the Years 2014, 2023 & 2030
REST OF WORLD
- Recombinant DNA Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
TABLE 30: USA Historic Review for Recombinant DNA Technology by Product Type - Medical and Non-Medical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 31: USA 16-Year Perspective for Recombinant DNA Technology by Product Type - Percentage Breakdown of Value Sales for Medical and Non-Medical for the Years 2014, 2023 & 2030
TABLE 32: USA Recent Past, Current & Future Analysis for Recombinant DNA Technology by Type - Expression System and Cloning Vector - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 33: USA Historic Review for Recombinant DNA Technology by Type - Expression System and Cloning Vector Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 34: USA 16-Year Perspective for Recombinant DNA Technology by Type - Percentage Breakdown of Value Sales for Expression System and Cloning Vector for the Years 2014, 2023 & 2030
TABLE 35: USA Recent Past, Current & Future Analysis for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 36: USA Historic Review for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 37: USA 16-Year Perspective for Recombinant DNA Technology by Application - Percentage Breakdown of Value Sales for Health & Disease, Food & Agriculture, Environmental and Other Applications for the Years 2014, 2023 & 2030
CANADA
TABLE 38: Canada Recent Past, Current & Future Analysis for Recombinant DNA Technology by Product Type - Medical and Non-Medical - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 39: Canada Historic Review for Recombinant DNA Technology by Product Type - Medical and Non-Medical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 40: Canada 16-Year Perspective for Recombinant DNA Technology by Product Type - Percentage Breakdown of Value Sales for Medical and Non-Medical for the Years 2014, 2023 & 2030
TABLE 41: Canada Recent Past, Current & Future Analysis for Recombinant DNA Technology by Type - Expression System and Cloning Vector - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 42: Canada Historic Review for Recombinant DNA Technology by Type - Expression System and Cloning Vector Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 43: Canada 16-Year Perspective for Recombinant DNA Technology by Type - Percentage Breakdown of Value Sales for Expression System and Cloning Vector for the Years 2014, 2023 & 2030
TABLE 44: Canada Recent Past, Current & Future Analysis for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 45: Canada Historic Review for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 46: Canada 16-Year Perspective for Recombinant DNA Technology by Application - Percentage Breakdown of Value Sales for Health & Disease, Food & Agriculture, Environmental and Other Applications for the Years 2014, 2023 & 2030
JAPAN
- Recombinant DNA Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
TABLE 48: Japan Historic Review for Recombinant DNA Technology by Product Type - Medical and Non-Medical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 49: Japan 16-Year Perspective for Recombinant DNA Technology by Product Type - Percentage Breakdown of Value Sales for Medical and Non-Medical for the Years 2014, 2023 & 2030
TABLE 50: Japan Recent Past, Current & Future Analysis for Recombinant DNA Technology by Type - Expression System and Cloning Vector - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 51: Japan Historic Review for Recombinant DNA Technology by Type - Expression System and Cloning Vector Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 52: Japan 16-Year Perspective for Recombinant DNA Technology by Type - Percentage Breakdown of Value Sales for Expression System and Cloning Vector for the Years 2014, 2023 & 2030
TABLE 53: Japan Recent Past, Current & Future Analysis for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 54: Japan Historic Review for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 55: Japan 16-Year Perspective for Recombinant DNA Technology by Application - Percentage Breakdown of Value Sales for Health & Disease, Food & Agriculture, Environmental and Other Applications for the Years 2014, 2023 & 2030
CHINA
- Recombinant DNA Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
TABLE 57: China Historic Review for Recombinant DNA Technology by Product Type - Medical and Non-Medical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 58: China 16-Year Perspective for Recombinant DNA Technology by Product Type - Percentage Breakdown of Value Sales for Medical and Non-Medical for the Years 2014, 2023 & 2030
TABLE 59: China Recent Past, Current & Future Analysis for Recombinant DNA Technology by Type - Expression System and Cloning Vector - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 60: China Historic Review for Recombinant DNA Technology by Type - Expression System and Cloning Vector Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 61: China 16-Year Perspective for Recombinant DNA Technology by Type - Percentage Breakdown of Value Sales for Expression System and Cloning Vector for the Years 2014, 2023 & 2030
TABLE 62: China Recent Past, Current & Future Analysis for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 63: China Historic Review for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 64: China 16-Year Perspective for Recombinant DNA Technology by Application - Percentage Breakdown of Value Sales for Health & Disease, Food & Agriculture, Environmental and Other Applications for the Years 2014, 2023 & 2030
EUROPE
- Recombinant DNA Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
TABLE 66: Europe Historic Review for Recombinant DNA Technology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 67: Europe 16-Year Perspective for Recombinant DNA Technology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
TABLE 68: Europe Recent Past, Current & Future Analysis for Recombinant DNA Technology by Product Type - Medical and Non-Medical - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 69: Europe Historic Review for Recombinant DNA Technology by Product Type - Medical and Non-Medical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 70: Europe 16-Year Perspective for Recombinant DNA Technology by Product Type - Percentage Breakdown of Value Sales for Medical and Non-Medical for the Years 2014, 2023 & 2030
TABLE 71: Europe Recent Past, Current & Future Analysis for Recombinant DNA Technology by Type - Expression System and Cloning Vector - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 72: Europe Historic Review for Recombinant DNA Technology by Type - Expression System and Cloning Vector Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 73: Europe 16-Year Perspective for Recombinant DNA Technology by Type - Percentage Breakdown of Value Sales for Expression System and Cloning Vector for the Years 2014, 2023 & 2030
TABLE 74: Europe Recent Past, Current & Future Analysis for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 75: Europe Historic Review for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 76: Europe 16-Year Perspective for Recombinant DNA Technology by Application - Percentage Breakdown of Value Sales for Health & Disease, Food & Agriculture, Environmental and Other Applications for the Years 2014, 2023 & 2030
FRANCE
- Recombinant DNA Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
TABLE 78: France Historic Review for Recombinant DNA Technology by Product Type - Medical and Non-Medical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 79: France 16-Year Perspective for Recombinant DNA Technology by Product Type - Percentage Breakdown of Value Sales for Medical and Non-Medical for the Years 2014, 2023 & 2030
TABLE 80: France Recent Past, Current & Future Analysis for Recombinant DNA Technology by Type - Expression System and Cloning Vector - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 81: France Historic Review for Recombinant DNA Technology by Type - Expression System and Cloning Vector Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 82: France 16-Year Perspective for Recombinant DNA Technology by Type - Percentage Breakdown of Value Sales for Expression System and Cloning Vector for the Years 2014, 2023 & 2030
TABLE 83: France Recent Past, Current & Future Analysis for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 84: France Historic Review for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 85: France 16-Year Perspective for Recombinant DNA Technology by Application - Percentage Breakdown of Value Sales for Health & Disease, Food & Agriculture, Environmental and Other Applications for the Years 2014, 2023 & 2030
GERMANY
- Recombinant DNA Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
TABLE 87: Germany Historic Review for Recombinant DNA Technology by Product Type - Medical and Non-Medical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 88: Germany 16-Year Perspective for Recombinant DNA Technology by Product Type - Percentage Breakdown of Value Sales for Medical and Non-Medical for the Years 2014, 2023 & 2030
TABLE 89: Germany Recent Past, Current & Future Analysis for Recombinant DNA Technology by Type - Expression System and Cloning Vector - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 90: Germany Historic Review for Recombinant DNA Technology by Type - Expression System and Cloning Vector Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 91: Germany 16-Year Perspective for Recombinant DNA Technology by Type - Percentage Breakdown of Value Sales for Expression System and Cloning Vector for the Years 2014, 2023 & 2030
TABLE 92: Germany Recent Past, Current & Future Analysis for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 93: Germany Historic Review for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 94: Germany 16-Year Perspective for Recombinant DNA Technology by Application - Percentage Breakdown of Value Sales for Health & Disease, Food & Agriculture, Environmental and Other Applications for the Years 2014, 2023 & 2030
ITALY
TABLE 95: Italy Recent Past, Current & Future Analysis for Recombinant DNA Technology by Product Type - Medical and Non-Medical - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 96: Italy Historic Review for Recombinant DNA Technology by Product Type - Medical and Non-Medical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 97: Italy 16-Year Perspective for Recombinant DNA Technology by Product Type - Percentage Breakdown of Value Sales for Medical and Non-Medical for the Years 2014, 2023 & 2030
TABLE 98: Italy Recent Past, Current & Future Analysis for Recombinant DNA Technology by Type - Expression System and Cloning Vector - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 99: Italy Historic Review for Recombinant DNA Technology by Type - Expression System and Cloning Vector Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 100: Italy 16-Year Perspective for Recombinant DNA Technology by Type - Percentage Breakdown of Value Sales for Expression System and Cloning Vector for the Years 2014, 2023 & 2030
TABLE 101: Italy Recent Past, Current & Future Analysis for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 102: Italy Historic Review for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 103: Italy 16-Year Perspective for Recombinant DNA Technology by Application - Percentage Breakdown of Value Sales for Health & Disease, Food & Agriculture, Environmental and Other Applications for the Years 2014, 2023 & 2030
UNITED KINGDOM
- Recombinant DNA Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
TABLE 105: UK Historic Review for Recombinant DNA Technology by Product Type - Medical and Non-Medical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 106: UK 16-Year Perspective for Recombinant DNA Technology by Product Type - Percentage Breakdown of Value Sales for Medical and Non-Medical for the Years 2014, 2023 & 2030
TABLE 107: UK Recent Past, Current & Future Analysis for Recombinant DNA Technology by Type - Expression System and Cloning Vector - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 108: UK Historic Review for Recombinant DNA Technology by Type - Expression System and Cloning Vector Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 109: UK 16-Year Perspective for Recombinant DNA Technology by Type - Percentage Breakdown of Value Sales for Expression System and Cloning Vector for the Years 2014, 2023 & 2030
TABLE 110: UK Recent Past, Current & Future Analysis for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 111: UK Historic Review for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 112: UK 16-Year Perspective for Recombinant DNA Technology by Application - Percentage Breakdown of Value Sales for Health & Disease, Food & Agriculture, Environmental and Other Applications for the Years 2014, 2023 & 2030
REST OF EUROPE
TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Recombinant DNA Technology by Product Type - Medical and Non-Medical - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 114: Rest of Europe Historic Review for Recombinant DNA Technology by Product Type - Medical and Non-Medical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 115: Rest of Europe 16-Year Perspective for Recombinant DNA Technology by Product Type - Percentage Breakdown of Value Sales for Medical and Non-Medical for the Years 2014, 2023 & 2030
TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Recombinant DNA Technology by Type - Expression System and Cloning Vector - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 117: Rest of Europe Historic Review for Recombinant DNA Technology by Type - Expression System and Cloning Vector Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 118: Rest of Europe 16-Year Perspective for Recombinant DNA Technology by Type - Percentage Breakdown of Value Sales for Expression System and Cloning Vector for the Years 2014, 2023 & 2030
TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 120: Rest of Europe Historic Review for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 121: Rest of Europe 16-Year Perspective for Recombinant DNA Technology by Application - Percentage Breakdown of Value Sales for Health & Disease, Food & Agriculture, Environmental and Other Applications for the Years 2014, 2023 & 2030
ASIA-PACIFIC
- Recombinant DNA Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
TABLE 123: Asia-Pacific Historic Review for Recombinant DNA Technology by Product Type - Medical and Non-Medical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 124: Asia-Pacific 16-Year Perspective for Recombinant DNA Technology by Product Type - Percentage Breakdown of Value Sales for Medical and Non-Medical for the Years 2014, 2023 & 2030
TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Recombinant DNA Technology by Type - Expression System and Cloning Vector - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 126: Asia-Pacific Historic Review for Recombinant DNA Technology by Type - Expression System and Cloning Vector Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 127: Asia-Pacific 16-Year Perspective for Recombinant DNA Technology by Type - Percentage Breakdown of Value Sales for Expression System and Cloning Vector for the Years 2014, 2023 & 2030
TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 129: Asia-Pacific Historic Review for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 130: Asia-Pacific 16-Year Perspective for Recombinant DNA Technology by Application - Percentage Breakdown of Value Sales for Health & Disease, Food & Agriculture, Environmental and Other Applications for the Years 2014, 2023 & 2030
REST OF WORLD
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Amgen Inc
- Bamboo Therapeutics, Inc.
- Biocon
- Biogen
- Chiron Corporation
- Cibus
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd
- Genentech, Inc
- GenScript
- GlaxoSmithKline plc.
- Horizon Discovery Group plc
- Merck KGaA
- Monsanto Company
- New England Biolabs
- Novartis AG
- Novo Nordisk A/S
- Nucelis
- Pfizer Inc.
- Profacgen
- Sanofi
- Syngene
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 88 |
| Published | April 2024 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 64.7 Billion |
| Forecasted Market Value ( USD | $ 93.7 Billion |
| Compound Annual Growth Rate | 4.7% |
| Regions Covered | Global |
